| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |